Measures beta-C-terminal telopeptide (β-CTX), a fragment released during the breakdown of type I collagen and a marker of bone resorption.
Used to assess bone turnover and monitor response to antiresorptive osteoporosis treatment, and as an adjunct in conditions associated with increased bone resorption.